Evidence map›Paper›PMID 28887890›Full record

ArticleElectrophoresis2017

Optimization of capillary zone electrophoresis for charge heterogeneity testing of biopharmaceuticals using enhanced method development principles.

Bernd Moritz, Valentina Locatelli, Michele Niess, Andrea Bathke, Steffen Kiessig, Barbara Entler, Christof Finkler, Harald Wegele, Jan Stracke

Abstract read
In one paragraph

Article in Electrophoresis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bernd MoritzF. Hoffmann-La Roche Ltd, Basel, Switzerland.ORCID 0000-0001-9116-1878
Valentina LocatelliF. Hoffmann-La Roche Ltd, Basel, Switzerland.
Michele NiessF. Hoffmann-La Roche Ltd, Basel, Switzerland.
Andrea BathkeF. Hoffmann-La Roche Ltd, Basel, Switzerland.
Steffen KiessigF. Hoffmann-La Roche Ltd, Basel, Switzerland.
Barbara EntlerIMC Fachhochschule Krems, University of Applied Sciences, Krems, Austria.
Christof FinklerF. Hoffmann-La Roche Ltd, Basel, Switzerland.
Harald WegeleF. Hoffmann-La Roche Ltd, Penzberg, Germany.
Jan StrackeF. Hoffmann-La Roche Ltd, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CZE is a well-established technique for charge heterogeneity testing of biopharmaceuticals. It is based on the differences between the ratios of net charge and hydrodynamic radius. In an extensive intercompany study, it was recently shown that CZE is very robust and can be easily implemented in labs that did not perform it before. However, individual characteristics of some examined proteins resulted in suboptimal resolution. Therefore, enhanced method development principles were applied here to investigate possibilities for further method optimization. For this purpose, a high number of different method parameters was evaluated with the aim to improve CZE separation. For the relevant parameters, design of experiments (DoE) models were generated and optimized in several ways for different sets of responses like resolution, peak width and number of peaks. In spite of product specific DoE optimization it was found that the resulting combination of optimized parameters did result in significant improvement of separation for 13 out of 16 different antibodies and other molecule formats. These results clearly demonstrate generic applicability of the optimized CZE method. Adaptation to individual molecular properties may sometimes still be required in order to achieve optimal separation but the set screws discussed in this study [mainly pH, identity of the polymer additive (HPC versus HPMC) and the concentrations of additives like acetonitrile, butanolamine and TETA] are expected to significantly reduce the effort for specific optimization.

Indexed as

Antibodies, MonoclonalElectrophoresis, CapillaryResearch DesignAntibodies, MonoclonalCapillary zone electrophoresisCharge heterogeneity testingDesign of experimentsMonoclonal antibody

Identifiers

PMID28887890
PMCPMC5765393

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.